Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo
Open accessAbstract
Apolipoprotein E (apoE) is an important determinant for the uptake of triglyceride-rich lipoproteins and emulsions by the liver, but the intracellular pathway of apoE following particle internalization is poorly defined. In the present study, we investigated whether retroendocytosis is a unique feature of apoE as compared with apoB by studying the intracellular fate of very low density lipoprotein-sized apoE-containing triglyceride-rich emulsion particles and LDL after LDLr-mediated uptake. Incubation of HepG2 cells with [(3)H]cholesteryl oleate-labeled particles at 37 degrees C led to a rapid release of [(3)H]cholesterol within 30 min for both LDL and emulsion particles. In contrast, emulsion-derived (125)I-apoE was more resistant to degradation (>/=120 min) than LDL-derived (125)I-apoB (30 min). Incubation at 18 degrees C, which allows endosomal uptake but prevents lysosomal degradation, with subsequent incubation at 37 degrees C resulted in a time-dependent release of intact apoE from the cells (up to 14% of the endocytosed apoE at 4 h). The release of apoE was accelerated by the presence of protein-free emulsion (20%) or high density lipoprotein (26%). Retroendocytosis of intact particles could be excluded since little intact [(3)H]cholesteryl oleate was released (<3%). In contrast, the degradation of LDL was complete with virtually no secretion of intact apoB into the medium. The intracellular stability of apoE was also demonstrated after hepatic uptake in C57Bl/6 mice. Intravenous injection of (125)I-apoE and [(3)H]cholesteryl oleate-labeled emulsions resulted in efficient LDLr-mediated uptake of both components by the liver (45-50% of the injected dose after 20 min). At 1 h after injection, only 15-20% of the hepatic (125)I-apoE was degraded, whereas 75% of the [(3)H]cholesteryl oleate was hydrolyzed. From these data we conclude that following LDLr-mediated internalization by liver cells, apoE can escape degradation and can be resecreted. This sequence of events may allow apoE to participate in its hypothesized intracellular functions such as mediator of the post-lysosomal trafficking of lipids and very low density lipoprotein assembly.
AI snapshot
Written from the paper’s full text.
TL;DR
Apolipoprotein E (apoE) delivered to hepatocytes via LDL receptor-mediated uptake of VLDL-sized triglyceride-rich emulsions is relatively resistant to intracellular degradation compared with apoB or the emulsion cholesteryl oleate core. In vitro, intact apoE can be resecreted by retroendocytosis, and in mice hepatic apoE remains largely undegraded at 1 h after uptake.
Key findings
- In HepG2 cells, emulsion-derived apoE degradation began slowly (≥120 min) and reached only 19% at 4 h, whereas cholesteryl oleate hydrolysis began within 30 min and reached 47% at 4 h; LDL-derived apoB degradation began within 30 min.
- After 18 °C pulse labeling and 37 °C chase, intact apoE was released from HepG2 cells up to 14% of endocytosed apoE at 4 h, increasing to 20% with protein-free emulsion and 26% with HDL; intact particle retroendocytosis was excluded because <3% of [³H]cholesteryl oleate was released intact.
- In C57Bl/6KH mice, apoE-enriched emulsions showed efficient LDLr-mediated liver uptake (45–50% of injected dose at 20 min); at 1 h only 15–20% of hepatic ¹²⁵I-apoE was degraded, whereas 75% of [³H]cholesteryl oleate was hydrolyzed.
- Hepatic uptake of lipid-associated apoE was 43.7 ± 2.3% of dose at 20 min, with 36.3 ± 2.1% still present in liver at 60 min and only 8.8 ± 0.2% degradation products at 60 min.
Methods
- In vitro: HepG2 cells were incubated with VLDL-sized apoE-containing triglyceride-rich emulsions (mean diameter 44.3 ± 2.6 nm) or LDL; binding was measured at 4 °C, uptake/degradation at 37 °C, and retroendocytosis was assessed by 18 °C pulse-chase followed by 37 °C incubation with or without HDL or protein-free emulsion.
- Radioactivity was analyzed by TCA precipitation for protein degradation, thin-layer chromatography for cholesteryl oleate hydrolysis, density gradient ultracentrifugation, and SDS-PAGE.
- In vivo: 10–12-week-old male C57Bl/6KH mice received intravenous ¹²⁵I-apoE- and [³H]cholesteryl oleate-labeled apoE emulsions; serum decay and liver uptake/degradation were measured over time.
Limitations
- The paper states that in vivo retroendocytosis is hard to establish conclusively under the present experimental conditions; the in vivo work shows hepatic stability but does not directly demonstrate resecretion.
- The mechanism of apoE retroendocytosis remains unresolved; the authors note it may differ from transferrin recycling and that alternative explanations such as pH-dependent aggregation require further investigation.
- Evident from the text: the in vivo data are from two experiments (“means ± variation of two experiments”), and the study does not test extrahepatic cells such as macrophages, which the authors mention would be needed to extend implications to reverse cholesterol transport.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 69 cited sources checked · 0 supported · 0 flagged
- Findingown data§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
Incubation of HepG2 cells with [3H]cholesteryl oleate-labeled particles at 37 °C led to a rapid release of [3H]cholesterol within 30 min for both LDL and emulsion particles.
“Incubation of HepG2 cells with [ 3 H]cholesteryl oleate-labeled particles at 37 °C led to a rapid release of [ 3 H]cholesterol within 30 min for both LDL and emulsion particles.”
Quote in the paperNot a substantial claim - Findingown data§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
Intravenous injection of 125I-apoE and [3H]cholesteryl oleate-labeled emulsions resulted in efficient LDLr-mediated uptake of both components by the liver (45-50% of the injected dose after 20 min).
“Intravenous injection of 125 I-apoE and [ 3 H]cholesteryl oleate-labeled emulsions resulted in efficient LDLr-mediated uptake of both components by the liver (45-50% of the injected dose after 20 min).”
Quote in the paperSubstantial claim - Findingown data§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
The intracellular stability of apoE was also demonstrated after hepatic uptake in C57Bl/6 mice.
“The intracellular stability of apoE was also demonstrated after hepatic uptake in C57Bl/6 mice.”
Quote in the paperSubstantial claim - Findingown data§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
Incubation at 18 °C, which allows endosomal uptake but prevents lysosomal degradation, with subsequent incubation at 37 °C resulted in a time-dependent release of intact apoE from the cells (up to 14% of the endocytosed apoE at 4 h).
“Incubation at 18 °C, which allows endosomal uptake but prevents lysosomal degradation, with subsequent incubation at 37 °C resulted in a time-dependent release of intact apoE from the cells (up to 14% of the endocytosed apoE at 4 h).”
Quote in the paperSubstantial claim - Findingown data§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
Emulsion-derived 125I-apoE was more resistant to degradation (>120 min) than LDL-derived 125I-apoB (30 min).
“In contrast, emulsion-derived 125 I-apoE was more resistant to degradation (>120 min) than LDL-derived 125 I-apoB (30 min).”
Quote in the paperSubstantial claim
- Findingown data§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
The release of apoE was accelerated by the presence of protein-free emulsion (20%) or high density lipoprotein (26%).
“The release of apoE was accelerated by the presence of protein-free emulsion (20%) or high density lipoprotein (26%).”
Quote in the paperNot a substantial claim - Findingown data§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
ApoE is resecreted at least in vitro.
“and that apoE is resecreted at least in vitro.”
Quote in the paperSubstantial claim - Findingown data§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
ApoE is relatively resistant to intracellular degradation as compared with the cholesteryl oleate moiety of the emulsion both in HepG2 cells in vitro and in hepatocytes in vivo in C57Bl/6KH mice.
“The data show that apoE is indeed relatively resistant to intracellular degradation as compared with the cholesteryl oleate (CO) moiety of the emulsion both in hepatoma cells in vitro (HepG2) and in hepatocytes in vivo (C57Bl/6KH mice)”
Quote in the paperSubstantial claim - Findingown data
Intrahepatic hydrolysis of [3H]CO from the injected apoE emulsion is rapid and efficient, with 50% hydrolysis achieved at 45 min after injection in mice.
“In contrast, the intrahepatic hydrolysis of [ 3 H]CO was rapid and efficient, with 50% hydrolysis achieved at 45 min after injection.”
Quote in the paperSubstantial claim - Findingcitation
For 125I-LDL in HepG2 cells, virtually all radioactivity released into the medium is trichloroacetic acid-soluble (>95%).
“In contrast to apoE, virtually all radioactivity released into the medium was trichloroacetic acid-soluble (Ͼ95%) (data not shown), which is in full accordance with our previous observations (28).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
After pulse labeling HepG2 cells with apoE emulsions at 18°C and subsequent incubation at 37°C, a time-dependent release of intact apoE into the medium occurs, amounting to 14% of the initially endocytosed apoE.
“After pulse labeling of HepG2 cells with apoE emulsions at 18 °C, and subsequent incubation at 37 °C, a time-dependent release of intact apoE into the medium (14% of the initially endocytosed apoE) could be detected.”
Quote in the paperSubstantial claim - Findingown data
In HepG2 cells loaded with 125I-LDL (10 μg/ml), cellular 125I-apoB radioactivity decreases with a half-life of approximately 2 h.
“In the same experimental set up, loading of HepG2 cells with 125 I-LDL (10 g/ml) resulted in a decrease of cellular 125 I-apoB radioactivity with a half-life of ϳ2 h.”
Quote in the paperSubstantial claim - Findingown data
LDL efficiently inhibited the binding of the radiolabeled apoE emulsions for at least 93-94%.
“LDL also efficiently inhibited the binding of the radiolabeled apoE emulsions for at least 93-94% (Fig. 2, B and C).”
Quote in the paperSubstantial claim - Findingown data
The total binding values of [3H]CO-labeled and 125I-labeled apoE emulsions to HepG2 cells are similar (55.3 ± 3.4 and 51.5 ± 3.6 ng protein/mg cell protein, respectively).
“The total binding values of the emulsions, calculated from the specific radioactivities of either the [ 3 H]CO-labeled and 125 I-labeled emulsions, were similar (55.3 Ϯ 3.4 and 51.5 Ϯ 3.6 ng of protein/mg of cell protein, respectively)”
Quote in the paperNot a substantial claim - Findingown data
The CO and apoE components of apoE emulsions showed a similar time-dependent cellular uptake.
“The CO and apoE components showed a similar time-dependent cellular uptake.”
Quote in the paperSubstantial claim - Findingown data
The release of apoE from HepG2 cells is increased to up to 20% and 26% in the presence of protein-free emulsion or HDL in the medium, respectively.
“The release of apoE was increased to up to 20 and 26% in the presence of the proteinfree emulsion or HDL in the medium, respectively.”
Quote in the paperSubstantial claim - Findingown data
The initial rates of serum clearance and liver uptake of the protein and lipid components of the apoE emulsion are essentially similar in mice.
“The initial rate of serum clearance and liver uptake of the protein and lipid components of the emulsion were essentially similar (Fig. 7).”
Quote in the paperSubstantial claim - Findingown data
The apoE associated with the emulsion and HDL fractions after ultracentrifugation is intact, as shown by detection of a radiolabeled 34-kDa protein by non-reducing SDS-PAGE.
“The integrity of apoE on these particles was confirmed by the detection of a radiolabeled 34-kDa protein in these fractions after protein separation by non-reducing 4 -20% gradient SDS-PAGE, followed by imaging (insets in Fig. 6, B and C).”
Quote in the paperSubstantial claim - Findingreasoning
The initial rate of CO hydrolysis from LDL appears faster than apoB degradation in HepG2 cells.
“although the initial rate of CO hydrolysis appears to be faster than apoB degradation (Fig. 4).”
Quote in the paperNot a substantial claim - Findingown data
HSPG contribute only a low extent (~10%) to binding of apoE emulsion to HepG2 cells, as determined after heparinase treatment.
“binding), whereas HSPG contributed for only a low extent (ϳ10%) as determined after treatment of the cells with heparinase.”
Quote in the paperNot a substantial claim - Findingown data
Addition of a physiologically relevant number of apoE molecules per particle (27 ± 2 at a 50:3 weight ratio) results in a 5-fold increased cellular association of the emulsion CO core.
“In contrast, the addition of a physiologically relevant number of apoE molecules per particle (27 Ϯ 2 at a 50:3 weight ratio), which is similar to the apoE content of rat VLDL (29 g/mg of TG, corresponding to 26 molecules per particle) (61), resulted in a 5-fold increased cellular association of the emulsion CO core.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
The stability of lipid-associated apoE in mouse liver is confirmed by a low level of degradation products, only 8.8 ± 0.2% of recovered radioactivity at 60 min after injection.
“The stability of lipid-associated apoE was also confirmed by a low level of degradation products in the liver, reaching only 8.8 Ϯ 0.2% of the recovered radioactivity at 60 min after injection (Fig. 8).”
Quote in the paperSubstantial claim - Findingown data
Association and degradation of the apoE emulsion by HepG2 cells depend on the presence of apoE.
“The association and degradation of the emulsion by HepG2 cells appeared to be dependent on the presence of apoE.”
Quote in the paperSubstantial claim - Findingown data
Binding of apoE emulsion to HepG2 cells is largely mediated by the LDL receptor (~90% of total binding).
“The binding of the emulsion to HepG2 cells appeared to be largely mediated by the LDLr (ϳ90% of the total”
Quote in the paperNot a substantial claim - Findingown data
Only a minor effect of heparinase treatment (12-17% reduction) was observed on the binding of both the [3H]CO-labeled and 125I-labeled apoE-enriched emulsions.
“In contrast, only a minor effect of heparinase treatment (12-17% reduction) was observed on the binding of both the [ 3 H]CO-labeled and 125 Ilabeled apoE-enriched emulsions (incubated at a TG:apoE ϭ 50:3 weight ratio).”
Quote in the paperSubstantial claim - Findingown data
ApoE is far more resistant to intracellular degradation as compared with apoB.
“It appears that apoE is far more resistant to intracellular degradation as compared with apoB.”
Quote in the paperSubstantial claim - Findingown data
When media from HepG2 cells incubated with 125I-apoE emulsions were subjected to density gradient ultracentrifugation, 45 and 50-60% of trichloroacetic acid-precipitable radioactivity were recovered in the emulsion and HDL fractions, respectively, when those acceptors were present.
“Whereas both intact and degraded apoE were detected in the bottom fractions of the tubes from media without acceptor (Fig. 6A), 45 and 50 -60% of the trichloroacetic acid-precipitable radioactivity were recovered in the emulsion and HDL fractions when the respective acceptors were present in the media (Fig. 6, B and C).”
Quote in the paperSubstantial claim - Findingown data
The binding of both the [3H]CO-labeled and 125I-labeled apoE-enriched emulsions was dose-dependently inhibited by an excess of unlabeled particles.
“The binding of both the [ 3 H]CO-labeled and 125 I-labeled apoE-enriched emulsions was dose-dependently inhibited by an excess of unlabeled particles (Fig. 2, B and C).”
Quote in the paperSubstantial claim - Findingown data
The involvement of apoE in the cellular uptake of the emulsion was confirmed by a 5-fold increase in the total CO uptake as compared with the apoE-free emulsion.
“The involvement of apoE in the cellular uptake of the emulsion was confirmed by a 5-fold increase in the total CO uptake as compared with the apoE-free emulsion (not shown).”
Quote in the paperNot a substantial claim - Findingown data
A time-dependent decrease in the cellular association of apoE was observed in the absence of acceptor, with 52 ± 4% of the radioactivity still associated with the cells after 60 min of incubation.
“A time-dependent decrease in the cellular association of apoE was observed in the absence of acceptor, with 52 Ϯ 4% of the radioactivity still associated with the cells after 60 min of incubation.”
Quote in the paperSubstantial claim - Interpretationown data§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
Retroendocytosis of intact particles could be excluded because little intact [3H]cholesteryl oleate was released (<3%).
“Retroendocytosis of intact particles could be excluded since little intact [ 3 H]cholesteryl oleate was released (<3%).”
Quote in the paperSubstantial claim - Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
The LDLr pathway plays a substantially greater role in the overall clearance of TG-rich lipoprotein remnants in mice than the non-LDLr pathway.
“However, the LDLr pathway plays a substantially greater role in the overall clearance of TG-rich lipoprotein remnants in mice than the non-LDLr pathway (15,16).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [15]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [16]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
When lipoproteins or emulsions are provided with at least four molecules of apoE, their affinity for the LDLr is 20-25-fold higher than for LDL.
“In either case, when lipoproteins or emulsions are provided with at least four molecules of apoE, their affinity for the LDLr is 20 -25-fold higher than for LDL (21)(22)(23).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [21]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [22]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [23]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
LDL shows a single interaction of apoB with the LDLr.
“Whereas LDL shows a single interaction of apoB with the LDLr”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
Four molecules of apoE on TG-containing lipoproteins can bind a single LDLr.
“four molecules of apoE on TG-containing lipoproteins can bind a single LDLr (21).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
The multivalent binding of apoE-containing particles leading to cross-linking of LDLrs may explain the delayed perinuclear lysosomal targeting of β-VLDL, VLDL, and LPL-treated VLDL as compared with LDL after equally rapid endocytosis by macrophages, human fibroblasts, and HepG2 cells.
“The multivalent binding of apoEcontaining particles leading to the cross-linking of LDLrs may explain the delayed perinuclear lysosomal targeting of -VLDL, VLDL, and (LPL-treated) VLDL as compared with LDL after equally rapid endocytosis by macrophages (24 -26), human fibroblasts (27), and HepG2 cells (28), respectively.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [26]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [27]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [28]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
ApoE-containing lipoproteins can interact with multiple LDLrs.
“In addition, apoE-containing lipoproteins can interact with multiple LDLrs (22).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
Lipoprotein-derived apoE that is taken up by cells may serve VLDL assembly, since apoE from radiolabeled VLDL remnants could be recovered in hepatic Golgi fractions after intravenous injection into mice.
“Although de novo synthesized apoE in hepatocytes (37) may be used for VLDL assembly, lipoproteinderived apoE that is taken up by the cells may also serve this purpose since apoE from radiolabeled VLDL remnants could be recovered in hepatic Golgi fractions (exocytotic compartments) after intravenous injection into mice (38).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [37]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [38]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (
Small particles (<50 nm) are almost exclusively recognized and taken up by the LDLr.
“small particles (Ͻ50 nm) are almost exclusively recognized and taken up by the LDLr (17,18).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [17]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [18]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
The apoE-emulsion particle binds to HepG2 cells as a unity, without preferential binding of either the lipid or protein moiety.
“which indicates that the apoE-emulsion particle binds to the cell as a unity, without preferential binding of either the lipid or protein moiety (Fig. 2).”
Quote in the paperSubstantial claim - Interpretationown data
The emulsion particles were taken up as unity, since the total uptake of both the CO and apoE moieties (11.6 nmol of CO and 5.3 g of apoE per mg of cell protein at 4 h) is proportional to the ratio of these components in the emulsion (1.9 nmol of CO per g of apoE).
“The emulsion particles were taken up as unity since the total uptake of both the CO and apoE moieties (11.6 nmol of CO and 5.3 g of apoE per mg of cell protein at 4 h) is proportional to the ratio of these components in the emulsion (1.9 nmol of CO per g of apoE).”
Quote in the paperSubstantial claim - Premisecitation
The metabolic behavior of the TG-rich emulsions in vivo is completely dependent on the presence of the LDL receptor, as determined by kinetic studies in wild-type versus LDLr-deficient mice.
“The metabolic behavior of these particles in vivo is completely dependent on the presence of the LDLr, as determined by kinetic studies on [ 3 H]CO-labeled emulsions in wild-type versus LDLr-deficient mice (18).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
The results are not confounded by the presence of apoE homodimers.
“It can thus be excluded that the results are confounded by the presence of apoE homodimers (48).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [48]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
Retroendocytosis is a unique feature of apoE as compared with apoB.
“It is thus clear that retroendocytosis is a unique feature of apoE as compared with apoB.”
Quote in the paperSubstantial claim - Interpretationcitation
These data are in full agreement with the observed relative intracellular stability of apoE compared with apoB after uptake by human fibroblasts and mouse J774 macrophages.
“These data are in full agreement with the observed relative intracellular stability of apoE as compared with apoB after uptake by human fibroblasts and mouse J774 macrophages (30).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Protein-free emulsion or HDL in the medium can act as potential acceptors of secreted apoE.
“emulsion or HDL in the medium as potential acceptors of secreted apoE (55-57)”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
The rate of apoE retroendocytosis may be underestimated because a considerable amount of newly synthesized apoE remains associated with cells instead of being secreted into the medium.
“In all cases, the rate of apoE retroendocytosis may even be underestimated, since it is known that a considerable amount of newly synthesized apoE remains associated with cells instead of being secreted into the medium (56,63).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [63]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Previous pulse-chase experiments with radioiodinated VLDL also resulted in the appearance of intact protein in the medium.
“Previous pulse-chase experiments with radioiodinated VLDL also resulted in the appearance of intact protein in the medium (28).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
ApoE is relatively resistant to degradation after cellular uptake by hepatoma cells in vitro and hepatocytes in vivo.
“In conclusion, we have shown that apoE is relatively resistant to degradation after cellular uptake by hepatoma cells in vitro and hepatocytes in vivo and that retroendocytosis of apoE occurs at least in vitro.”
Quote in the paperSubstantial claim - Interpretationown data
Retroendocytosis of apoE occurs at least in vitro.
“In conclusion, we have shown that apoE is relatively resistant to degradation after cellular uptake by hepatoma cells in vitro and hepatocytes in vivo and that retroendocytosis of apoE occurs at least in vitro.”
Quote in the paperSubstantial claim
- May combine two claims. 35
- Classified as probably not a substantial claim. 19
May combine two claims.
Findingown data§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (The degradation of LDL was complete with virtually no secretion of intact apoB into the medium.
“In contrast, the degradation of LDL was complete with virtually no secretion of intact apoB into the medium.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (At 1 h after injection, only 15-20% of the hepatic 125I-apoE was degraded, whereas 75% of the [3H]cholesteryl oleate was hydrolyzed.
“At 1 h after injection, only 15-20% of the hepatic 125 I-apoE was degraded, whereas 75% of the [ 3 H]cholesteryl oleate was hydrolyzed.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataThe apoE contents of the reisolated emulsions were 4.6 ± 1.1 g/mg TG (50:0.3) and 34.2 ± 2.6 g/mg TG (50:3.0), corresponding to 4 ± 1 and 27 ± 2 molecules of apoE per particle.
“The apoE contents of the reisolated emulsions were 4.6 Ϯ 1.1 g/mg TG (50:0.3)and 34.2 Ϯ 2.6 g/mg TG (50:3.0),which corresponds to 4 Ϯ 1 and 27 Ϯ 2 molecules of apoE per particle.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingcitationThe emulsions were homogeneous with respect to size (low polydispersity of 0.23-0.31) and the mean particle diameter was 44.3 ± 2.6 nm (mean ± S.D.; n = 6) as determined by photon correlation spectroscopy.
“The emulsions were homogeneous with respect to size (low polydispersity of 0.23-0.31)and the mean particle diameter was 44.3 Ϯ 2.6 nm (mean Ϯ S.D.; n ϭ 6) as determined by photon correlation spectroscopy using a Malvern 4700 C system (Malvern Instruments, Malvern, UK) (18).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingown dataIncubation of HepG2 cells with [3H]CO or 125I-apoB-labeled LDL (20 g of protein/ml), which resulted in a similar rate of particle uptake as compared with apoE emulsions (~10^12 particles per mg of cell protein at 4 h), led to the rapid onset of both [3H]CO hydrolysis and 125I-apoB degradation (both within 30 min).
“Incubation of HepG2 cells with [ 3 H]CO or 125 I-apoB-labeled LDL (20 g of protein/ ml), which resulted in a similar rate of particle uptake as compared with apoE emulsions (ϳ10 12 particles per mg of cell protein at 4 h), led to the rapid onset of both [ 3 H]CO hydrolysis and 125 I-apoB degradation (both within 30 min) (not shown).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe hydrolysis of CO started within 30 min after incubation and was very effective (47% of the total uptake at 4 h).
“However, whereas the hydrolysis of CO started within 30 min after incubation and was very effective (47% of the total uptake at 4 h)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt 60 min, the cell association was reduced to 45 ± 1% (p < 0.05) and 38 ± 3% (p < 0.01) in the presence of the protein-free emulsion or HDL, respectively.
“At this time point, the cell association was reduced to 45 Ϯ 1% (Student's t test; p Ͻ 0.05) and 38 Ϯ 3% (p Ͻ 0.01) in the presence of the protein-free emulsion or HDL, respectively.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationEmulsion-bound 125I-apoE was only monomeric.
“In contrast, emulsion-bound 125 I-apoE was only monomeric, which confirms earlier observations that the interaction of apoE homodimers with lipidic particles does not withstand ultracentrifugation conditions (48).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingown dataThe presence of protein-free emulsion or HDL had no effect on the degradation rate of 125I-apoE but did result in a significantly increased secretion rate of trichloroacetic acid-precipitable radioactivity (representing intact protein) as compared with the absence of acceptor.
“The presence of these acceptors had no effect on the degradation rate of 125 I-apoE but did result in a significantly increased secretion rate of trichloroacetic acid-precipitable radioactivity (representing intact protein) as compared with the absence of acceptor (repeated measures analysis of variance, p Ͻ 0.01 and p Ͻ 0.001, respectively).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataApoE released from cells by retroendocytosis can recombine with both protein-deficient emulsion and HDL.
“We observed that apoE, which is released from cells by retroendocytosis, can recombine with both the protein-deficient emulsion and HDL.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth the presence of emulsion and HDL in the medium stimulated retroendocytosis of apoE, without an effect on apoE degradation.
“Both the presence of the emulsion and HDL in the medium stimulated retroendocytosis of apoE, without an effect on apoE degradation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRadioiodinated apoE contained some disulfide-linked apoE homodimers, but analysis of emulsion-bound 125I-apoE confirmed that radioactivity was associated with 34-kDa apoE only.
“Whereas radioiodinated apoE did contain some disulfide-linked apoE homodimers, analysis of emulsion-bound 125 I-apoE confirmed that the radioactivity was associated with 34-kDa apoE only.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe degradation of the apoE moiety started slowly (≥120 min) and was to a much lower extent (19% at 4 h).
“the degradation of the apoE moiety started slowly (Ն120 min) and was to a much lower extent (19% at 4 h).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHepatic uptake of lipid-associated apoE (43.7 ± 2.3% of dose at 20 min) is not coupled to rapid degradation, with 36.3 ± 2.1% still present in liver at 60 min after injection in mice.
“The hepatic uptake of lipid-associated apoE (43.7 Ϯ 2.3% of the dose at 20 min after injection) was not coupled to rapid degradation, as 36.3Ϯ 2.1% was still present within the liver at 60 min after injection.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataInjection of an equal dose of lipid-free 125I-apoE into mice leads to rapid elimination of 80% of the injected dose from serum within 2 min and high liver uptake (70% at 5 min).
“In contrast, injection of an equal dose of 125 I-apoE in a lipid-free state led to the rapid elimination of 80% of the injected dose from the serum within 2 min, with a high uptake by the liver (70% at 5 min after injection).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPreassociation of apoE with [3H]CO-labeled emulsion accelerates serum clearance (t1/2 <10 min) and liver uptake (~50% at 20 min) of the emulsion in mice.
“As shown in Fig. 7, preassociation of apoE with the [ 3 H]CO-labeled emulsion accelerated the serum clearance (t1 ⁄2 Ͻ 10 min) and liver uptake (ϳ50% at 20 min) of the emulsion.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn HepG2 cells loaded with [3H]CO-labeled apoE emulsions at 18°C, more than 90% of the cell-associated radiolabel is hydrolyzed to [3H]cholesterol after 4 h at 37°C, while less than 3% of the initially cell-associated radiolabel remains as intact [3H]CO in the medium.
“Loading the cells with [ 3 H]CO-labeled apoE emulsions at 18 °C led to the hydrolysis of the vast majority of radiolabel into [ 3 H]cholesterol (Ͼ90%) after 4 h of incubation at 37 °C, whereas hardly any intact [ 3 H]CO could be detected in the medium (Ͻ3% of the initially cell-associated radiolabel) (not shown).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationMost LDL-derived apoB is recovered in the medium in a degraded state (>95%), confirming previous observations.
“By contrast, most LDL-derived apoB was recovered in the medium in a degraded state (Ͼ95%), which confirms previous observations (28,62).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [28]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [62]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingown dataAn apoE-deficient emulsion shows low cellular association and degradation, which is not substantially increased by addition of 4 ± 1 molecules of apoE per emulsion particle at a TG:apoE = 50:0.3 weight ratio.
“The apoE-deficient emulsion showed a low cellular association and degradation, which was not substantially increased by the addition of 4 Ϯ 1 molecules of apoE per emulsion particle, obtained at a TG:apoE ϭ 50:0.3 weight ratio (not shown).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataEmulsion-derived apoE is much more resistant to intracellular degradation than LDL-derived apoB, as evident from a later onset of protein degradation (120 versus 30 min) and a much lower degradation rate.
“Emulsion-derived apoE is much more resistant to intracellular degradation as compared with LDL-derived apoB, as evident from a later onset of protein degradation (120 versus 30 min) and a much lower degradation rate (Fig. 4).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAfter radiolabeling of apoE, 96% of the 125I-activity could be recovered at the position of monomeric apoE (34 kDa).
“After radiolabeling of apoE, 96% of the 125 I-activity could be recovered at the position of monomeric apoE (34 kDa).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAfter simultaneous hepatic uptake of both the particle core and preassociated apoE (45-50% of injected dose at 20 min), only 10-20% of apoE is degraded in contrast to as much as 75% of the CO moiety at 1 h after injection in mice.
“Indeed, it appeared that after simultaneous hepatic uptake of both the particle core (reflected by the CO moiety) and the preassociated apoE (45-50% of the injected dose at 20 min after injection), only 10 -20% of the apoE is degraded in contrast to as much as 75% of the CO moiety at 1 h after injection (Figs. 7 and 8).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown data§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (Following LDLr-mediated internalization by liver cells, apoE can escape degradation and can be resecreted.
“From these data we conclude that following LDLr-mediated internalization by liver cells, apoE can escape degradation and can be resecreted.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (ApoE plays a key role in the hepatic metabolism of triglyceride-rich lipoproteins such as chylomicrons and very low density lipoproteins and of triglyceride-rich emulsions.
“Apolipoprotein E (apoE) 1 plays a key role in the hepatic metabolism of triglyceride (TG)-rich lipoproteins such as chylomicrons and very low density lipoproteins (VLDL) (1-3) and TG-rich emulsions (4 -5).”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [1]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [2]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [3]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [4]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [5]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (This sequence of events may allow apoE to participate in its hypothesized intracellular functions such as mediator of the post-lysosomal trafficking of lipids and very low density lipoprotein assembly.
“This sequence of events may allow apoE to participate in its hypothesized intracellular functions such as mediator of the post-lysosomal trafficking of lipids and very low density lipoprotein assembly.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Interpretationreasoning§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (Since these emulsions mimic TG-rich lipoproteins, apoE delivered to the hepatocyte as a constituent of chylomicron remnants can possibly be re-used for intracellular lipid trafficking, such as the assembly and secretion of VLDL, or may participate in lipoprotein remnant internalization via the secretion-recapture pathway.
“Since these emulsions mimic TG-rich lipoproteins, we anticipate that apoE, which has been delivered to the hepatocyte as a constituent of chylomicron remnants, can possibly be re-used for intracellular lipid trafficking, such as the assembly and secretion of VLDL, or may participate in lipoprotein remnant internalization via the “secretion-recapture” pathway (40,41).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [41]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (The affinity of TG-rich lipoproteins and emulsions for the LDLr pathway and non-LDLr pathway is governed by their particle size.
“It has been shown that the affinity of TG-rich lipoproteins and emulsions for the LDLr pathway and non-LDLr pathway is governed by their particle size.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [17]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [18]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (Small apoE-containing TG-rich emulsions mimic the metabolic fate of TG-rich lipoproteins in the blood and are exclusively taken up via the LDLr in mice.
“For this purpose, we utilized small apoE-containing TGrich emulsions that mimic the metabolic fate of TG-rich lipoproteins in the blood (4,39) and are exclusively taken up via the LDLr in mice (18).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [4]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [39]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [18]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataUsing this method, 99.6% of the emulsion-associated 3H radioactivity appeared as [3H]CO.
“Using this method, 99.6% of the emulsion-associated 3 H radioactivity appeared as [ 3 H]CO.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (Preliminary data on radioiodinated apoE emulsions and LDL suggest that, in contrast to the efficient degradation of apoB, the degradation of apoE may be retarded, whereas fluorescently labeled lipids in TG-rich particles and LDL followed a similar intracellular route toward lysosomes.
“Preliminary data on radioiodinated apoE emulsions and LDL suggest that, in contrast to the efficient degradation of apoB, the degradation of apoE may be retarded, whereas fluorescently labeled lipids in TG-rich particles and LDL followed a similar intracellular route toward lysosomes (29,30).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [29]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [30]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim. May combine two claims.
Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (LDL's protein and lipid components are completely degraded within perinuclear lysosomes while the receptor recycles back to the cell surface.
“of which both the protein and lipid components are completely degraded within perinuclear lysosomes while the receptor recycles back to the cell surface (19,20).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [19]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [20]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (ApoE appeared to have a physiological role in the assembly and secretion of VLDL.
“In addition, apoE appeared to have a physiological role in the assembly and secretion of VLDL (34 -36).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [34]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [35]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [36]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (Large particles are mainly processed via the liver-specific non-LDLr recognition site.
“Whereas large particles are mainly processed via the liver-specific non-LDLr recognition site”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [17]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [18]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo EVIDENCE FOR RETROENDOCYTOSIS* (Initial data suggested that apoE affects the transport and metabolism of free fatty acids and free cholesterol released from the lysosomes.
“Initial data suggested that apoE affects the transport and metabolism of free fatty acids and free cholesterol released from the lysosomes (33).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationIncubation at 18 °C does not impair binding and endocytosis, but blocks the fusion of endosomes with lysosomes.
“Cells were preincubated in the presence of 125 I-apoE-containing emulsions (60 g of TG/ ml) for 3 h at 18 °C, which does not impair binding and endocytosis, but blocks the fusion of endosomes with lysosomes.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [51]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [52]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataMore than 97, 98.5, and 99.5% of the radiolabels in LDL, apoE, and bLf, respectively, were 10% trichloroacetic acid-precipitable.
“More than 97, 98.5, and 99.5% of the radiolabels in LDL, apoE, and bLf, respectively, were 10% trichloroacetic acid-precipitable.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataBoth emulsion particles and HDL can function as acceptors of secreted apoE, with HDL more effective than emulsion particles in stimulating total release of apoE under the given conditions.
“Apparently, both emulsion particles and HDL can function as acceptors of secreted apoE, albeit that HDL is more effective than emulsion particles in stimulation of the total release of apoE under the given conditions (Fig. 5).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe apoE content of rat VLDL is 29 μg/mg TG, corresponding to 26 molecules per particle.
“which is similar to the apoE content of rat VLDL (29 g/mg of TG, corresponding to 26 molecules per particle) (61)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim.
PremisecitationAfter cellular uptake of LDL, both its protein and lipid constituents follow the same lysosomal pathway.
“After cellular uptake of LDL, both its protein and lipid constituents follow the same lysosomal pathway (19,20)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [19]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [20]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Study design and conductcitationHeparinase treatment inhibited binding of bovine lactoferrin (bLf) to HepG2 cells by 45%, demonstrating that HSPG had been effectively removed.
“In accordance with previous observations by Ji and Mahley (59), heparinase treatment inhibited the binding of bLf to HepG2 cells by 45%, which demonstrates that HSPG had been effectively removed.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationown dataThe present data rule out that secretion of intact particles occurs upon endocytosis and show that apoE can selectively undergo retroendocytosis.
“Our present data rule out that secretion of intact particles occurs upon endocytosis but rather show that apoE can selectively undergo retroendocytosis.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe finding that HSPG are hardly involved in binding of apoE emulsion particles is in agreement with previous observations that, as opposed to LPL, apoE is not essential for binding of β-VLDL to HSPG.
“The finding that HSPG are hardly involved in the binding of apoE emulsion particles is in agreement with our previous observations that, as opposed to LPL, apoE is not essential for the binding of -VLDL”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationown dataApoE emulsions, after LDLr-mediated uptake, may have a different intracellular fate as compared with LDL, as a result of which apoE may partially escape from lysosomal degradation.
“These data thus indicate that apoE emulsions, after LDLr-mediated uptake, may have a different intracellular fate as compared with LDL, as a result of which apoE may (partially) escape from lysosomal degradation.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationCell surface-bound apoE is released by a wash with heparin.
“cell surface-bound apoE was released by a subsequent wash with heparin (770 units/ml in DMEM ϩ 1% BSA) (53,54).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [53]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim.
PremisecitationDegradation of 125I-protein in the medium can be determined by separating 125I-protein from degradation products by 10% trichloroacetic acid precipitation.
“Degradation of 125 I-protein in the medium was determined by separating 125 I-protein from degradation products by 10% trichloroacetic acid precipitation as described (19).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationown dataThe applied apoE-emulsion particles are almost exclusively recognized by the LDLr on HepG2 cells in vitro, whereas HSPG play only a minor role in particle recognition.
“Taking these data together, it is evident that the applied apoE-emulsion particles are also almost exclusively recognized by the LDLr on HepG2 cells in vitro, whereas HSPG play only a minor role in particle recognition.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationThe fact that transferrin recycling in HepG2 cells occurs with a half-time of less than 10 min, whereas apoE is slowly and gradually released after pulse labeling, suggests that mechanisms other than transferrin-like CURL shuttling account for apoE escaping degradation.
“The fact that the recycling of transferrin in HepG2 cells occurs with a half-time of less than 10 min (64), whereas apoE is slowly and gradually released from these cells after pulse labeling, suggests that other mechanisms should account for escaping degradation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim.
PremisecitationNewly synthesized apoE that is secreted and bound to cell surface HSPG can be re-endocytosed upon binding of lipoproteins (secretion-recapture pathway).
“It is already known that newly synthesized apoE that is secreted and bound to cell surface HSPG can be re-endocytosed upon the binding of lipoproteins (so called secretion-recapture pathway) (40,41,57).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [41]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNewly synthesized apoE that binds to the cell surface may partially be proteolytically degraded upon re-entry into the cell.
“In addition, newly synthesized apoE that binds to the cell surface may partially be proteolytically degraded upon re-entry into the cell (57).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
The paper relies on this without support.
The intracellular pathway of apoE following particle internalization is poorly defined.
“but the intracellular pathway of apoE following particle internalization is poorly defined.”
The paper relies on this without support.
The VLDL-sized TG-rich emulsion enriched with radiolabeled apoE is a valid model for the intracellular fate of apoE in native TG-rich lipoproteins.
“In order to chase the intracellular fate of apoE only, we thus decided to utilize VLDL-sized TG-rich emulsions (44 Ϯ 3 nm) that can be enriched with radiolabeled apoE (4,18).”
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751 · see citing works
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/y59-099 · Cited by 23,189 · see citing works
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · see citing works
Efficient Trace-labelling of Proteins with Iodine
McFarlane, A. S. (1958) · Nature · doi:10.1038/182053a0 · Cited by 2,559 · see citing works
[19] Receptor-mediated endocytosis of low-density lipoprotein in cultured cells
Goldstein, J. L., Basu, S. K., & Brown, M. S. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)98152-1 · Cited by 1,623 · see citing works
Binding and Degradation of Low Density Lipoproteins by Cultured Human Fibroblasts
Goldstein, J. L., & Brown, M. S. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42341-7 · Cited by 1,485 · see citing works
pH and the recycling of transferrin during receptor-mediated endocytosis.
Dautry‐Varsat, A., Ciechanover, A. J., & Lodish, H. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.8.2258 · Cited by 1,178 · see citing works
Separation of plasma lipoproteins by density-gradient ultracentrifugation
Redgrave, T. G., Roberts, D., & West, C. E. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90488-1 · Cited by 1,101 · see citing works
Herz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohlꝉ, H., & Stanley, K. K. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03306.x · Cited by 955 · see citing works
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830 · see citing works
Receptor-mediated endocytosis: insights from the lipoprotein receptor system.
Brown, M. S., & Goldstein, J. L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3330 · Cited by 711 · see citing works
Mahley, R. W., & Ji, Z.-S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33334-4 · Cited by 693 · see citing works
The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding protein
Beisiegel†, U., Weber, W. T., Ihrke, G., Herz, J., & Stanley, K. K. (1989) · Nature · doi:10.1038/341162a0 · Cited by 680 · see citing works
Dunn, W. A., Hubbard, A. L., & Aronson, N. N. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70726-1 · Cited by 452 · see citing works
Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat.
Wu, A. L., & Windmueller, H. G. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50321-5 · Cited by 446 · see citing works
Windler, E., Chao, Y., & Havel, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70647-4 · Cited by 365 · see citing works
Inhibition of Hepatic Chylomicron Remnant Uptake by Gene Transfer of a Receptor Antagonist
Willnow, T. E., Sheng, Z., Ishibashi, S., & Herz, J. (1994) · Science · doi:10.1126/science.7515194 · Cited by 301 · see citing works
Innerarity, T. L., Pitas, R. E., & Mahley, R. W. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50713-4 · Cited by 300 · see citing works
The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
Innerarity, T. L., Friedlander, E. J., Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44180-9 · Cited by 276 · see citing works
Ji, Z. S., Brecht, W. J., Miranda, R. D., Hussain, M. M., Innerarity, T. L., & Mahley, R. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82186-x · Cited by 240 · see citing works
Pitas, R. E., Innerarity, T. L., Arnold, K. S., & Mahley, R. W. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2311 · Cited by 213 · see citing works
Ji, Z. S., Fazio, S., Lee, Y. L., & Mahley, R. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42009-6 · Cited by 209 · see citing works
Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia
Huang, Y., Liu, X. Q., Rall, S. C., Taylor, J. M., von Eckardstein, A., Assmann, G., & Mahley, R. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26388 · Cited by 204 · see citing works
Kuipers, F., Jong, M. C., Lin, Y., Eck, M. V., Havinga, R., Bloks, V. W., Verkade, H. J., Hofker, M. H., Moshage, H. J., van Berkel, T. J. C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119841 · Cited by 167 · see citing works
Self-citationRensen, P. C. N., Herijgers, N., Netscher, M. H., Meskers, S. C. J., Eck, M. V., & van Berkel, T. J. C. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37190-x · Cited by 165 · see citing works
Self-citationGianturco, S. H., Gotto, A. M., Hwang, S. L., Karlin, J. B., Lin, A., Prasad, S. C., & Bradley, W. A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32655-3 · Cited by 162 · see citing works
Metabolism of protein-free lipid emulsion models of chylomicrons in rats
Redgrave, T. G., & Maranhão, R. C. (1985) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(85)90036-0 · Cited by 162 · see citing works
Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections
Hamilton, R., Wong, J., Guo, L., Krisans, S. K., & Havel, R. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42343-0 · Cited by 152 · see citing works
Rensen, P. C. N., van Dijk, M. C. M., Havenaar, E. C., Bijsterbosch, M. K., Kruijt, J. K., & van Berkel, T. J. C. (1995) · Nature Medicine · doi:10.1038/nm0395-221 · Cited by 147 · see citing works
Self-citationRensen, P. C. N., & van Berkel, T. J. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14791 · Cited by 144 · see citing works
Self-citationJi, Z.-S., Pitas, R. E., & Mahley, R. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13452 · Cited by 134 · see citing works
Role of the Low Density Lipoprotein (LDL) Receptor Pathway in the Metabolism of Chylomicron Remnants
Ishibashi, S., Perrey, S., Chen, Z., Osuga, J.-I., Shimada, M., Ohashi, K., Harada, K., Yazaki, Y., & Yamada, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22422 · Cited by 129 · see citing works
Tabas, I. A., Lim, S. K., Xu, X. X., & Maxfield, F. R. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.3.929 · Cited by 127 · see citing works
Ji, Z. S., & Mahley, R. W. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.12.2025 · Cited by 117 · see citing works
Weisgraber, K. H., & Shinto, L. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99060-5 · Cited by 104 · see citing works
van Dijk, M. C. M., Ziere, G. J., BOERS, W., Linthorst, C., Bijsterbosch, M. K., & van Berkel, T. J. C. (1991) · Biochemical Journal · doi:10.1042/bj2790863 · Cited by 91 · see citing works
Vogel, T., Weisgraber, K. H., Zeevi, M. I., Ben-Artzi, H., Levanon, A. Z., Rall, S. C., Innerarity, T. L., Hui, D. Y., Taylor, J. M., & Kanner, D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8696 · Cited by 88 · see citing works
Dahan, S., Ahluwalia, J. P., Wong, L., Posner, B. I., & Bergeron, J. J. M. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.1859 · Cited by 85 · see citing works
Choi, S., & Cooper, A. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82326-2 · Cited by 79 · see citing works
Heeren, J., Weber, W. T., & Beisiegel†, U. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.3.349 · Cited by 78 · see citing works
Tabas, I. A., Myers, J. N., Innerarity, T. L., Xu, X. X., Arnold, K. S., Boyles, J. K., & Maxfield, F. R. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.6.1547 · Cited by 77 · see citing works
Al-Haideri, M. T., Goldberg, I. J., Galeano, N. F., Gleeson, A. M., Vogel, T., Gorecki, M., Sturley, S. L., & Deckelbaum, R. J. (1997) · Biochemistry · doi:10.1021/bi9631024 · Cited by 76 · see citing works
Mortimer, B., Beveridge, D. J., Martins, I. J., & Redgrave, T. G. (1995) · PubMed · doi:10.1074/jbc.270.48.28767 · Cited by 74 · see citing works
Myers, J. N., Tabas, I. A., Jones, N. L., & Maxfield, F. R. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.123.6.1389 · Cited by 69 · see citing works
Schwiegelshohn, B., Presley, J. F., Gorecki, M., Vogel, T., Carpentier, Y., Maxfield, F. R., & Deckelbaum, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.4.1761 · Cited by 64 · see citing works
Shimano, H., Namba, Y., Ohsuga, J.-I., Kawamura, M., Yamamoto, K., Shimada, M., Gotoda, T., Harada, K., Yazaki, Y., & Yamada, N. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117218 · Cited by 57 · see citing works
Recycling of Apolipoprotein E in Mouse Liver
Fazio, S., Linton, M. F., Hasty, A. H., & Swift, L. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8247 · Cited by 53 · see citing works
Eisenberg, S., Friedman, G., & Vogel, T. (1988) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.8.5.480 · Cited by 53 · see citing works
Jäckle, S., Runquist, E. A., Miranda-Brady, S., & Havel, R. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52307-3 · Cited by 52 · see citing works
Regulation of apolipoprotein E secretion by high density lipoprotein 3 in mouse macrophages
Dory, L. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42030-9 · Cited by 50 · see citing works
Rensen, P. C. N., Schiffelers, R. M., Versluis, A. J., Bijsterbosch, M. K., Kuijk-Meuwissen, M. E. M. J. V., & van Berkel, T. J. C. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.445 · Cited by 49 · see citing works
Self-citationHeparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells.
Lilly-Stauderman, M., Brown, T., Balasubramaniam, A., & Harmony, J. A. K. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40746-1 · Cited by 44 · see citing works
Windler, E. E. T., Greeve, J. C., Robenek, H., Rinninger, F., Greten, H., & Jäckle, S. (1996) · Hepatology · doi:10.1053/jhep.1996.v24.pm0008690403 · Cited by 35 · see citing works
Lombardi, P., Mulder, M. T., van der Boom, H., Frants, R. R., & Havekes, L. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74288-4 · Cited by 34 · see citing works
Self-citationvan Dijk, K. W., van Vlijmen, B. J. M., Hof, H. B. V., van der Zee, A., Santamarina-Fojo, S., van Berkel, T. J. C., Havekes, L. M., & Hofker, M. H. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33374-5 · Cited by 31 · see citing works
Self-citationRetro-endocytosis of low density lipoprotein by cultured human skin fibroblasts.
Aulinskas, T. H., Oram, J. F., Bierman, E. L., Coetzee, G. A., Gevers, W., & van der Westhuyzen, D. R. (1985) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.5.1.45 · Cited by 25 · see citing works
de Beer, F., Hendriks, W. L., van Vark, L. C., Kamerling, S. W. A., van Dijk, K. W., Hofker, M. H., Smelt, A. H. M., & Havekes, L. M. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.633 · Cited by 22 · see citing works
Self-citationHuman plasma lipoproteins regulate apolipoprotein E secretion from a post-Golgi compartment.
Ye, S. Q., OLSON, L. M., Reardon, C. A., & Getz, G. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36706-7 · Cited by 20 · see citing works
Biessen, E. A. L., Vietsch, H., & van Berkel, T. J. C. (1994) · Biochemical Journal · doi:10.1042/bj3020283 · Cited by 19 · see citing works
Self-citationSchmitt, M., & Grand‐Perret, T. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33337-x · Cited by 16 · see citing works
Pulcini, T., Terru, P., Sparrow, J. T., Pownall, H. J., & Ponsin, G. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00156-s · Cited by 15 · see citing works
Low-density lipoproteins are degraded in HepG2 cells with low efficiency
Lombardi, P., Mulder, M. T., de Wit, E., van Berkel, T. J. C., Frants, R. R., & Havekes, L. M. (1993) · Biochemical Journal · doi:10.1042/bj2900509 · Cited by 11 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 3
- Beisiegel, 1995, Circulation, 92, I
- Chen, 1995, Circulation, 92, I
- Chen, 1997, Circulation, 96, I
Cited by
Sorted by citations
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · see citing works
Nair, J. K., Willoughby, J. L. S., Chan, A., Charisse, K., Alam, M. R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A. V., Milstein, S., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505986a · Cited by 1,141 · see citing works
Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
van Amersfoort, E. S., van Berkel, T. J. C., & Kuiper, J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.379-414.2003 · Cited by 750 · see citing works
PCSK9: From Basic Science Discoveries to Clinical Trials
Shapiro, M. D., Tavori, H., & Fazio, S. (2018) · Circulation Research · doi:10.1161/circresaha.118.311227 · Cited by 285 · see citing works
Pan, M., Cederbaum, A. I., Zhang, Y., Ginsberg, H. N., Williams, K. J., & Fisher, E. A. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19197 · Cited by 278 · see citing works
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting
Rensen, P. C. N., de Vrueh, R. L. A., Kuiper, J., Bijsterbosch, M. K., Biessen, E. A. L., & van Berkel, T. J. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00109-0 · Cited by 217 · see citing works
Self-citationPetrov, A. M., Kasimov, M. R., & Zefirov, A. L. (2016) · Acta Naturae · doi:10.32607/20758251-2016-8-1-58-73 · Cited by 194 · see citing works
HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis
Tsompanidi, E. M., Brinkmeier, M. S., Fotiadou, E. H., Giakoumi, S. M., & Kypreos, K. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.034 · Cited by 169 · see citing works
More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration
Lane-Donovan, C., Philips, G. T., & Herz, J. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.005 · Cited by 158 · see citing works
Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory
Li, X., Zhang, J., Li, D., He, C., He, K., Xue, T., Wan, L., Zhang, C., & Liu, Q. (2021) · Neuron · doi:10.1016/j.neuron.2021.01.005 · Cited by 165 · see citing works
Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation
Heeren, J., Grewal, T., Laatsch, A., Becker, N., Rinninger, F., Rye, K.-A., & Beisiegel, U. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409324200 · Cited by 139 · see citing works
Berbée, J. F. P., van der Hoogt, C. C., Sundararaman, D., Havekes, L. M., & Rensen, P. C. N. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400301-jlr200 · Cited by 137 · see citing works
Self-citationJong, M. C., Rensen, P. C. N., Dahlmans, V. E. H., van der Boom, H., van Berkel, T. J. C., & Havekes, L. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32211-2 · Cited by 136 · see citing works
Self-citationApolipoprotein E recycling: implications for dyslipidemia and atherosclerosis.
Heeren, J., Beisiegel, U., & Grewal, T. (2005) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000201282.64751.47 · Cited by 134 · see citing works
Dato, V. A., & Chiabrando, G. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061780 · Cited by 123 · see citing works
The cell biology of APOE in the brain
Windham, I. A., & Cohen, S. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.09.004 · Cited by 103 · see citing works
HDL endocytosis and resecretion
Röhrl, C., & Stangl, H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.07.014 · Cited by 100 · see citing works
Heeren, J., Grewal, T., Laatsch, A., Rottke, D., Rinninger, F., Enrich, C., & Beisiegel†, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209006200 · Cited by 98 · see citing works
Lipid metabolism and neuroinflammation in Alzheimer’s disease: a role for liver X receptors
Kang, J., & Rivest, S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1049 · Cited by 94 · see citing works
Duivenvoorden, I., Voshol, P. J., Rensen, P. C. N., van Duyvenvoorde, W., Romijn, J. A., EMEIS, J. J., Havekes, L. M., & Nieuwenhuizen, W. F. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.2.312 · Cited by 91 · see citing works
Self-citationAndrogen deficiency and atherosclerosis: The lipid link
Traish, A. M., Abdou, R. Y., & Kypreos, K. E. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.09.003 · Cited by 84 · see citing works
Rodenburg, K. W., & VANDERHORST, D. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.07.002 · Cited by 84 · see citing works
Duivenvoorden, I., Voshol, P. J., Rensen, P. C. N., van Duyvenvoorde, W., Romijn, J. A., EMEIS, J. J., Havekes, L. M., & Nieuwenhuizen, W. F. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.312 · Cited by 77 · see citing works
Self-citationRecycling of Apolipoprotein E and Lipoprotein Lipase through Endosomal Compartments in Vivo
Heeren, J., Grewal, T., Jäckle, S., & Beisiegel†, U. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107461200 · Cited by 74 · see citing works
Laatsch, A., Panteli, M., Sornsakrin, M., Hoffzimmer, B., Grewal, T., & Heeren, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029385 · Cited by 64 · see citing works
Li, L., Thompson, P. A., & Kitchens, R. L. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800172-jlr200 · Cited by 63 · see citing works
A Recycling Pathway for Resecretion of Internalized Apolipoprotein E in Liver Cells*
Swift, L., Farkas, M. H., Major, A., Valyi-Nagy, K., Linton, M., & Fazio, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100172200 · Cited by 69 · see citing works
Martinez‐Uña, M., Varela‐Rey, M., Mestre, D., Fernández-Ares, L., Fresnedo, O., Fernández‐Ramos, D., Juan, V. G., Martín‐Guerrero, I., García‐Orad, Á., Luka, Z., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.019 · Cited by 58 · see citing works
den Boer, M. A. M., Berbée, J. F. P., Reiss, P., van der Valk, M., Voshol, P. J., Kuipers, F., Havekes, L. M., Rensen, P. C. N., & Romijn, J. A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000194073.87647.10 · Cited by 58 · see citing works
Self-citationVan Hoof, D., Rodenburg, K. W., & Van der Horst, D. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.00113 · Cited by 53 · see citing works
Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocyte progenitor cells
Rogers, S. W., Gregori, N. Z., Carlson, N. G., Gahring, L. C., & Noble, M. (2001) · Glia · doi:10.1002/1098-1136(20010315)33:4 · Cited by 94 · see citing works
The Recycling of Apolipoprotein E in Primary Cultures of Mouse Hepatocytes
Farkas, M. H., Swift, L. L., Hasty, A. H., Linton, M. F., & Fazio, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208026200 · Cited by 46 · see citing works
Wu, C., Zhao, S., & Yu, B. (2014) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12116 · Cited by 44 · see citing works
Intracellular metabolism of triglyceride-rich lipoproteins
Heeren, J., & Beisiegel†, U. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00003 · Cited by 40 · see citing works
The recycling of apolipoprotein E in macrophages
Hasty, A. H., Plummer, M. R., Weisgraber, K. H., Linton, M. F., Fazio, S., & Swift, L. L. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400418-jlr200 · Cited by 39 · see citing works
Association of ApoE and LRP mRNA levels with dementia and AD neuropathology
Akram, A. M., Schmeidler, J., Katsel, P., Hof, P. R., & Haroutunian, V. H. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.010 · Cited by 37 · see citing works
Shimamura, M. (2001) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(01)00292-4 · Cited by 36 · see citing works
Intracellular Processing of Riboflavin in Human Breast Cancer Cells
Bareford, L. M., Phelps, M. A., Foraker, A. B., & Swaan, P. W. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800046m · Cited by 34 · see citing works
Role of LDL Cholesterol and Endolysosomes in Amyloidogenesis and Alzheimer’s Disease
Chen, X. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000236 · Cited by 30 · see citing works
High-density lipoprotein endocytosis in endothelial cells
Fruhwürth, S., Pavelka, M., Bittman, R., Kovacs, W. J., Walter, K., Röhrl, C., & Stangl, H. (2013) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v4.i4.131 · Cited by 26 · see citing works
Acidifying Endolysosomes Prevented Low-Density Lipoprotein-Induced Amyloidogenesis
Liang, H., Soliman, M. L., Geiger, N. H., Miller, N., Afghah, Z., Lakpa, K. L., Chen, X., & Geiger, J. D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180941 · Cited by 26 · see citing works
The recycling of apolipoprotein E and its amino-terminal 22 kDa fragment
Farkas, M. H., Weisgraber, K. H., Shepherd, V. L., Linton, M. F., Fazio, S., & Swift, L. L. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400104-jlr200 · Cited by 26 · see citing works
African Trypanosomes: Intracellular Trafficking of Host Defense Molecules1
Shiflett, A. M., Faulkner, S. D., Cotlin, L., Widener, J., Stephens, N. A., & Hajduk, S. L. (2006) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2006.00228.x · Cited by 25 · see citing works
Fabris, C., Toniutto, P., Bitetto, D., Minisini, R., Smirne, C., Caldato, M., & Pirisi, M. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01156.x · Cited by 23 · see citing works
Fan, J., Stukas, S. K., Wong, C. A., Chan, J., May, S., DeValle, N., Hirsch‐Reinshagen, V., Wilkinson, A., Oda, M. N., & Wellington, C. L. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014365 · Cited by 23 · see citing works
Transgenic Drosophila model to study apolipoprotein E4-induced neurodegeneration
Haddadi, M., Nongthomba, U., Jahromi, S. R., & Ramesh, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.022 · Cited by 20 · see citing works
Zinc affects the proteolytic stability of Apolipoprotein E in an isoform-dependent way
Xu, H. J., Gupta, V. B., Martins, I. J., Martins, R. N., Fowler, C. J., Bush, A. I., Finkelstein, D. I., & Adlard, P. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.016 · Cited by 19 · see citing works
α3‐Galactosylated glycoproteins can bind to the hepaticasialoglycoprotein receptor
Joziasse, D. H., Lee, R. T., Lee, Y. C., Biessen, E. A. L., Schiphorst, W. E. C. M., Koeleman, C. A. M., & EIJNDEN, D. H. V. D. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01747.x · Cited by 19 · see citing works
Self-citationThe Hyplip2 locus causes hypertriglyceridemia by decreased clearance of triglycerides
Moen, C. J. A., Tholens, A., Voshol, P. J., de Haan, W., Havekes, L. M., Gargalovic, P. S., Lusis, A. J., van Dijk, K. W., Frants, R. R., Hofker, M. H., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700009-jlr200 · Cited by 18 · see citing works
Self-citationAleong, R., Aumont, N., Dea, D., & Poirier, J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02869.x · Cited by 18 · see citing works
Apolipoprotein E intersects with amyloid-β within neurons
Konings, S. C., Nyberg, E., Martinsson, I., Torres-Garcia, L., Klementieva, O. L., Almeida, C. G., & Gouras, G. K. (2023) · Life Science Alliance · doi:10.26508/lsa.202201887 · Cited by 12 · see citing works
Guha, M., & Gursky, O. (2011) · Journal of Lipids · doi:10.1155/2011/493720 · Cited by 12 · see citing works
Physiological relevance of apolipoprotein E recycling: studies in primary mouse hepatocytes
Zhu, M.-Y., Hasty, A. H., Harris, C. M., Linton, M. F., Fazio, S., & Swift, L. L. (2005) · Metabolism · doi:10.1016/j.metabol.2005.04.019 · Cited by 12 · see citing works
CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice
Bijland, S., van den Berg, S. A. A., Voshol, P. J., van den Hoek, A. M., Princen, H. M. G., Havekes, L. M., Rensen, P. C. N., & van Dijk, K. W. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m900186-jlr200 · Cited by 11 · see citing works
Self-citationEffect of apoE/ATP‐containing liposomes on hepatic energy state
Chaı̈b, S., Charrueau, C., Neveux, N., Nakib, S., Chaumeil, J. C., Cynober, L., & Bandt, J. P. D. (2003) · Liver International · doi:10.1034/j.1478-3231.2003.00863.x · Cited by 11 · see citing works
Development of AD-Like Pathology in Skeletal Muscle
Chen, X., Miller, N. M., Afghah, Z., & Geiger, J. D. (2019) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000028 · Cited by 10 · see citing works
ENDOCYTOSIS OF apoE-EGFP BY PRIMARY HUMAN BRAIN CULTURES
DeKroon, R. M., & Armati, P. J. (2002) · Cell Biology International · doi:10.1006/cbir.2002.0930 · Cited by 9 · see citing works
DeKroon, R. M., & Armati, P. J. (2002) · Cell Biology International · doi:10.1006/cbir.2002.0868 · Cited by 9 · see citing works
Acute effects of interleukin-6 infusion on apo-B-containing lipoprotein subclasses in humans
Bagdade, J. D., Pedersen, B. K., Schwenke, D. C., Saremi, A., & Alaupovic, P. (2011) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2011.585404 · Cited by 8 · see citing works
Dynamic and stable pools of apoE differ functionally at the HepG2 cell surface
Burgess, J. W., & Marcel, Y. L. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30273-x · Cited by 8 · see citing works
Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease
Hone, E., Lim, F., & Martins, I. J. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch7 · Cited by 8 · see citing works
Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
van Amersfoort, E. S., & Kuiper, J. (2007) · CRC Press eBooks · doi:10.3109/9781420020595-21 · Cited by 6 · see citing works
Amyloid beta accumulation in HIV-1 infected brain: the role of altered cholesterol homeostasis.
Chen, X., Liang, H., & Geiger, J. D. (2014) · PubMed · Cited by 6 · see citing works
Genetics and molecular biology
Baralle, M., & Baralle, F. E. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200012000-00013 · Cited by 6 · see citing works
In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects
Dinkel, R. E., Barrett, P. H. R., Demant, T., & Parhofer, K. G. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.06.004 · Cited by 4 · see citing works
Receptor-Mediated Endocytosis and Intracellular Trafficking of Lipoproteins
Heeren, J., & Beisiegel†, U. (2009) · Springer eBooks · doi:10.1007/978-3-642-00300-4_8 · Cited by 4 · see citing works
Lampropoulou, A., Zannis, V. I., & Kypreos, K. E. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.09.006 · Cited by 3 · see citing works
Rensen, P. C. N., Sliedregt, L. A. J. M., van Santbrink, P. J., Ferns, M., Schifferstein, H. N. J., van Leeuwen, S. H., Souverijn, J. H. M., van Berkel, T. J. C., & Biessen, E. A. L. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000193620.98587.40 · Cited by 4 · see citing works
Self-citationLjungberg, M. C., Asuni, A., Pearce, J., Dayanandan, R., März, W., Hoffmann, M. M., Bertrand, P., Siest, G., Rupniak, H. T. R., Anderton, B. H., et al. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00064-8 · Cited by 2 · see citing works
Chen, X., Liang, H., & Geiger, J. D. (2014) · PubMed · Cited by 2 · see citing works
Autophagy-Derived Alzheimer’s Pathogenesis
Ling, D., & Paul, M. (2011) · InTech eBooks · doi:10.5772/17681 · Cited by 1 · see citing works
Swift, L. L., Hasty, A. H., Linton, M. F., & Fazio, S. (2007) · doi:10.1002/9783527625178.ch3 · Cited by 1 · see citing works
The effects of triglyceride on lysosomal function in macrophage foam cells.
Ullery, J. C. (2009) · Europe PMC (PubMed Central) · Cited by 1 · see citing works
Aspects involved in the (patho)physiology of the metabolic syndrome
Duivenvoorden, I. (2006) · Leiden Repository (Leiden University)
Modulation of VLDL triglyceride metabolism
Bijland, S. (2010) · Leiden Repository (Leiden University)
Differentielle Analyse des HDL-Proteoms mittels Massenspektrometrie
Zellbiologie, M., & Beisiegel†, U. (2010)
Amyloid Beta Accumulation in HIV-1 Infected Brain: The Role of Altered Cholesterol
Chen, X., Lü, H., & Jd, G. (2014)
Zellbiologie, M., Medizin, E., & Beisiegel†, U. (2005)
Aronsen, E. (2009) · Duo Research Archive (University of Oslo)
A novel pathway for VLDL assembly in the mouse liver
Mleczko, A. M. (2006) · doi:10.53846/goediss-179
- Authors
- Rensen, P. C. N., Jong, M. C., van Vark, L. C., van der Boom, H., Hendriks, W. L., van Berkel, T. J. C., Biessen, E. A. L., & Havekes, L. M.
- Affiliations
- Leiden University (NL)
- Netherlands Organisation for Applied Scientific Research (NL)
- Corresponding author
- Rensen, Patrick C.N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 275
- Issue
- 12
- Pages
- 8564-8571
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1982686316
- Semantic Scholar
- 12bda1313988653c9aba69a2666f7405a7c86220
- Cited by
- 86
- References
- 62
- Citations by year
- 2023: 2 · 2021: 2 · 2019: 3 · 2018: 3 · 2016: 1 · 2015: 2 · 2014: 8 · 2013: 2 · 2012: 3
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- TNO Repository (submittedVersion)
- Repository hosted by TU Delft Library (TU Delft) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- apolipoprotein E, intracellular degradation, triglyceride-rich lipoproteins, apolipoprotein B, cholesterol ester hydrolysis, hepatic lipoprotein uptake, HepG2 cells, C57BL/6 mice, post-translational processing
- MeSH terms
- Animals, Apolipoproteins B, Apolipoproteins E, Biological Transport, Blood, Cells, Cultured, Cholesterol Esters, Emulsions, Endocytosis, Lipoproteins, Lipoproteins, LDL, Lipoproteins, VLDL, Liver, Lysosomes, Male, Mice, Inbred C57BL, Protein Processing, Post-Translational, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-31.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-31.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review